Iran had reportedly pressed Buehler about the matter in the immediate aftermath of the La Belle bombing and subsequent ...

Detailed price information for Tvardi Therapeutics Inc (TVRD-Q) from The Globe and Mail including charting and trades.

Data from EULAR 2026 show that next-generation CAR T- and NK cell platforms induce powerful, drug-free clinical remissions in patients with highly refractory rheumatic diseases.

After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo treatment to a massive survival benefit versus late-day infusion in non-small cell ...

Americans love working from home. Does it love them back? A controversial new study says remote work is taking a toll on ...

Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.

Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about metabolism, peptides, and the future of self-driven health ...

FDA’s PDUFA goal date is November 1, 2026; If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease; CAMBRIDGE, Mass., Ju ...

Some of the earliest real-money online casinos offered only a small selection of games, with InterCasino often cited as ...

New human research reveals how gut bacteria and creatine may restore brain energy and improve depression. If you have or know ...

The class of drugs known as DNA Damage Response inhibitors, which work by blocking cancer cells’ ability to repair their own damaged DNA, is expanding rapidly beyond its original anchor, the PARP ...